logo
logo
AI

Discover the World’s Fastest Business Insights

Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.

Aspen RxHealth Raises $23M Series B Funding Round Led by Bessemer Venture Partners

Aspen RxHealth Raises $23M Series B Funding Round Led by Bessemer Venture Partners

01/07/21, 3:19 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgtampa
Money raised
$23 million
Round Type
series b
Aspen RxHealth, whose first of its kind clinical pharmacy model developed by pharmacists for pharmacists delivers value for health plans and risk-bearing providers, today announced the closure of a $23 million Series B funding round led by  Bessemer Venture Partners. Multiple strategic partners participated in this round, including Takeda Digital Ventures, dRx Capital (Novartis' Digital Venture Fund), and McKesson Ventures. Previous investors Humana and Flare Capital Partners also participated. This funding comes at the conclusion of a transformational year in both healthcare and for the company as a result of the rapid adoption of virtual care models

Company Info

Company
Aspen Rx Health
Location
tampa, florida, united states
Additional Info
Aspen RxHealth is the leader in next-generation clinical pharmacy services, intelligently matching pharmacists with patients based on often overlooked social and clinical factors to enrich the patient-pharmacist experience and drive better outcomes for health plans and other risk-bearing providers. Aspen RxHealth's community of more than 5,000 pharmacists is the largest in the nation, empowering patients with the information and action plans they need to achieve optimal health outcomes. Learn more at aspenrxhealth.com.
G2 High Performer Badge

Never Miss an Opportunity: Your #1 Sales Intelligence Tool

Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.